Patient Rights in Clinical Trials

Understanding your rights before, during, and after participation in a U.S. clinical trial. According to ClinicalTrials.gov, the National Institutes of Health public registry maintained by the U.S. National Library of Medicine catalogs more than 500,000 clinical studies across over 220 countries since 1997, with the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007 requiring registration for most studies of FDA-regulated products. Patient rights are protected by 21 CFR Part 50 (informed consent) and 45 CFR 46 (the federal Common Rule); see our methodology for source documents.

Participant rights at a glance

The four core rights below are not symbolic. Each is enforceable under a specific federal regulation and overseen by a specific authority. The table below maps each right to its regulatory source and the authority that enforces it.

Your Core Rights as a Trial Participant

The rights of clinical trial participants are protected by federal regulations, the Belmont Report principles, and institutional review boards (IRBs). Whether you're considering enrollment or already participating, you have fundamental protections.

The Right to Informed Consent

Before you can join a clinical trial, researchers must explain:

• The purpose of the study
• What you'll be asked to do and how long it will take
• All foreseeable risks and discomforts
• Potential benefits to you or others
• Alternative treatments outside the trial
• How your confidentiality will be maintained
• Whether compensation or treatment is available if injury occurs
• Contact information for questions

You must have time to review this document, ask questions, and decide without pressure. You should receive a copy of the signed consent form.

The Right to Withdraw

You may leave a clinical trial at any time, for any reason, without penalty or loss of benefits to which you're otherwise entitled. Participation is always voluntary. Withdrawing from a trial will not affect your regular medical care.

The Right to Privacy

Your personal health information is protected under HIPAA. Researchers must maintain the confidentiality of your data. In published results, you are identified by a participant number, never by name. The FDA and sponsor may review your records for audit purposes — this should be disclosed in your consent form.

The Right to Continued Care

Participating in a trial does not replace your regular healthcare. You retain the right to continue seeing your regular physician. If you experience adverse effects, the trial team must provide medical care or refer you to appropriate care.

Questions to Ask Before Enrolling

Before signing a consent form, consider asking:

• What is the purpose of this study?
• Has this treatment been tested in earlier phases? What were the results?
• What are the known side effects?
• What are the alternatives to participating?
• Will I know which group I'm in (treatment or placebo)?
• What happens if I experience side effects?
• Who will cover costs if I'm injured in the trial?
• Can I continue if the trial ends early?
• What happens to my data if I withdraw?

The Role of Institutional Review Boards (IRBs)

Every federally funded clinical trial must be reviewed and approved by an Institutional Review Board (IRB) — an independent committee that includes researchers, physicians, and community members. The IRB evaluates whether the study is ethical and whether the risks are reasonable compared to the benefits.

When IRB judgment shapes the trial

IRB review is not a one-time approval. The board continues monitoring as the trial runs, reviews protocol amendments, evaluates safety reports, and can suspend or terminate research that loses its risk-benefit justification. Participants who flag concerns to the IRB trigger this oversight even when the research team is dismissive.

Central IRBs for multi-site trials

Large multi-site trials often use a single central IRB rather than relying on each participating institution's local board. Central IRBs streamline approval and harmonize protocol oversight across sites, but participants should still know which IRB is the IRB of record for their specific enrollment site — the contact information is required to be in the consent form.

Reporting Concerns

If you believe your rights have been violated or you have concerns about the trial, you can contact:

• The IRB that oversees the study (contact info should be in your consent form)
• The Office for Human Research Protections (OHRP): hhs.gov/ohrp
• The FDA MedWatch program for reporting adverse events: fda.gov/safety/medwatch

Participation in a clinical trial is voluntary, and the right to withdraw at any time cannot be waived. Trials that pressure continued participation violate the most fundamental rule in human-subjects research.